Stock UniverseDerived research view · source repositories remain read-only

Guardant Health, Inc. (GH)

Life Science Tools / Diagnostics / MedTech · Healthcare / Diagnostics & Research
Score Band
High
Selection Score
41.19
Global Rank
291
Market Cap
12.32B
Latest Close
125.61
RS Composite
27.35% · G#330

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
36.16%
3M
37.73%
6M
18.54%
1Y
163.00%
3Y
328.41%
5Y
1.20%
10Y
290.09%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 3.35M · 30-day average: 2.33M · Max drawdown over stored range: -91.03%

Research Snapshot

Relative Strength vs SPX

RS Composite27.35%
20D RS35.51%
60D RS33.72%
120D RS16.91%
Global RS Rank330 · 90.16% percentile
Qualified+ RS Rank137 · 89.11% percentile
Group ScopeQualified+
Primary RS Rank9 · 93.66% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank29 / 246
Primary Percentile88.62
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-071.08Bn/a-447.56M-433.19M-3.41-373.36M63.99M-437.35M127Mn/a-41.43%-40.10%-34.56%-40.49%989.29M1.50B

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$-3.41-36.9x$8.4914.8x$-3.44-36.5x$-2.93-42.8x

Shares Diluted: 127M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue373.653449.538563.948739.016982.021
Revenue Growth (YoY)30.315%20.309%25.451%31.043%32.882%
Gross Profit250.741293.213336.896449.217633.014
Operating Income-411.001-544.378-481.325-443.594-434.284
Free Cash Flow-284.052-386.924-345.461-274.9430.0001
Free Cash Flow Per Share-2.804-3.787-3.085-2.2495
EPS (Diluted) GAAP-4.004086-6.406349-4.281253-3.555118-3.320281
EPS Growth
EPS Non-GAAP
Gross Margin67.105%65.225%59.739%60.786%64.46%
Operating Margin-109.995%-121.097%-85.349%-60.025%-44.223%
Profit Margin-108.569%-145.613%-85.017%-59.048%-42.39%
Free Cash Flow Margin-76.02%-86.071%-61.258%-37.204%9500%
Shares Outstanding (Diluted)101.314102.178111.988122.745125.374
Shares Change (YoY)3.908%0.853%9.601%9.605%2.142%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-07301.67Mn/a-121.35M-40.23%-112.08M-37.15%-0.85131.27M989.29M1.50Bprocessed
2025 Q42026-02-19281.27Mn/a-120.81M-42.95%-128.49M-45.68%-1.00128.69M378.20M1.50Bprocessed
2025 Q32025-10-29265.20Mn/a-98.99M-37.33%-92.72M-34.96%-0.74124.81M580.01M1.11Bprocessed
2025 Q22025-07-30232.09Mn/a-106.41M-45.85%-99.90M-43.04%-0.80124.11M629.14M1.12Bprocessed
2025 Q12025-04-30203.47Mn/a-111.04M-54.57%-95.16M-46.77%-0.77123.87M698.57M1.12Bprocessed
2024 Q42025-02-20201.81Mn/a-125.97M-62.42%-111.01M-55.00%-0.90123.76M623.54M1.14Bprocessed
2024 Q32024-11-06191.48Mn/a-117.33M-61.28%-107.75M-56.28%-0.88123.05M616.30M1.14Bprocessed
2024 Q22024-08-07177.24Mn/a-100.62M-56.77%-102.63M-57.91%-0.84122.45M986.16M1.14Bprocessed
2024 Q12024-05-09168.49Mn/a-99.68M-59.16%-114.98M-68.24%-0.94121.71M1.03B1.14Bprocessed
2023 Q42024-02-22155.05Mn/a-197.51M-1.27%-92.36M-59.57%-0.78118.58M1.13B1.14Bprocessed
2023 Q32023-11-06143.03Mn/a-113.54M-79.38%-86.10M-60.20%-0.73117.74M457.34M1.14Bprocessed
2023 Q22023-08-03137.15Mn/a-119.62M-87.22%-72.77M-53.06%-0.67108.81M271.07M1.14Bprocessed
2023 Q12023-05-09128.71Mn/a-134.06M-1.04%-133.53M-1.04%-1.30102.66M223.64M1.14Bprocessed
2022 Q42023-02-23126.89Mn/a-146.12M-1.15%n/an/an/a102.52M1.01B1.14Bprocessed
2022 Q32022-11-03117.40Mn/a-144.60M-1.23%n/an/a-1.58102.29M158.31M1.14Bprocessed
2022 Q22022-08-04109.14Mn/a-130.32M-1.19%n/an/a-2.25102.05M853.69M1.14Bprocessed
2022 Q12022-05-0596.10Mn/a-123.34M-1.28%n/an/a-1.21101.85M962.27M1.14Bprocessed
2021 Q42022-02-24108.11Mn/a-98.21M-90.84%n/an/an/a101.70M932.75M1.13Bprocessed
2021 Q32021-11-0494.78Mn/a-107.29M-1.13%n/an/a-1.06101.42M1.49B1.13Bprocessed
2021 Q22021-08-0592.10Mn/a-97.64M-1.06%n/an/a-0.96101.17M1.79B1.13Bprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.